Could your cancer treatment work better in the morning?
NCT ID NCT07338981
Summary
This study is testing whether the time of day when standard immunotherapy drugs are given affects how well they work for adults with advanced kidney cancer. Researchers will compare giving the treatment in the morning versus the afternoon to see if timing impacts survival, side effects, and the body's immune response. Participants will receive the same standard drugs but will be assigned to get them at a specific clinic time.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED KIDNEY CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
BC Cancer - Vancouver Cancer Centre
Vancouver, British Columbia, V5Z 4E6, Canada
Conditions
Explore the condition pages connected to this study.